Pigmented progressive purpuric dermatosis - Pigmentatus Progressivus Purpuric Dermatosishttps://en.wikipedia.org/wiki/Pigmented_purpuric_dermatosis
Pigmentatus Progressivus Purpuric Dermatosis (Pigmented progressive purpuric dermatosis) refertur ad cutem non prurientem, quae eruptions purpuricas cutis habet. Magnitudo laesionis est inter 0,3 et 1 cm et saepissime in extremis partibus cernitur. Cremor cortisone adiuvabit ad levandam pruritiem et discolorationem cutis. pigmentatus progressivus purpuric dermatosis (pigmented progressive purpuric dermatosis) nullas alias signa praeter colorem cutis exhibet. Vitia in partibus inferioribus frequentissima sunt, sed possunt etiam apparere in corpore, in manibus, cruribus, abdomine, etiam in collo.

Curatio OTC Medicamenta
OTC molecula unguentorum
#Hydrocortisone ointment
#Hydrocortisone cream
☆ AI Dermatology — Free Service
In anno 2022 Stiftung Warentest ex Germania provenit, satisfactio consumptoria cum ModelDerm paulo minus fuit quam cum consultationibus telemedicinis solutis.
  • Schamberg disease — viris XXVI annorum cum commissura pigmentationis asymptomaticae et telangiectasiae in crure.
    References Pigmented Purpuric Dermatoses: A Complete Narrative Review 34070260 
    NIH
    Pigmented purpuric dermatoses (PPD) coetus conditionum cutanearum sunt parvae areas sanguinis sub cute, quae inflammatione capillari signatae sunt. PPD typice manifestatur ut rubrae maculae purpureae, quae postea in aureo‑brunneas convertuntur, sicut hemosiderin resumitur.
    Pigmented purpuric dermatoses (PPD) include several skin diseases characterized by multiple petechial hemorrhage as consequence of capillaritis. PPD generally present with red to purple macules that progressively evolve to golden-brown color as the hemosiderin is reabsorbed.
     Schamberg Disease 32809367 
    NIH
    Schamberg disease frequentissimum est genus pigmentarum purpuricarum dermatosum (PPDs), quae sunt conditiones longae cutis cum maculis rubris vel purpureis propriae, et cum colorationibus cutis auctis (squamulae brunneae, rubrae vel flavae). PPDs in quinque speciebus collocantur: Schamberg's purpura, Majocchi purpura, lichen aureus, Gougerot‑Blum purpura, purpura eczematoides Doucas et Kapetanakis. Schamberg disease (SD) etiam nota est ut progressive pigmentaria dermatosis Schamberg, purpura pigmentosa progressiva, Schamberg's purpura. Schamberg disease maxime afficit crura inferiora, ubi typice apparet, sed etiam fieri potest in femoribus, natibus, trunco, brachiis.
    Schamberg disease represents the most common type of pigmented purpuric dermatoses (PPDs), a chronic, benign, cutaneous eruptions characterized by petechiae, purpura, and increased skin pigmentation (brown, red, or yellow patchy). The PPDs are grouped into five clinical entities: Schamberg's purpura, Majocchi purpura, lichen aureus, Gougerot-Blum purpura and, eczematoid-like purpura of Doucas and Kapetanakis. Schamber disease (SD) has also been called: progressive pigmentary dermatosis of Schamberg, purpura pigmentosa progressive and, Schamberg's purpura. It is commonly seen in males and mainly affects the tibial regions, and could involve thighs, buttocks, trunk, or upper extremities.
     Characteristics and Clinical Manifestations of Pigmented Purpuric Dermatosis 26273156 
    NIH
    Informatio de 113 aegeribus cum PPD enucleata est, ex quibus 38 subierunt biopsiam cutis ad hoc studium. Frequentissimum genus clinicum fuit morbus Schamberg (60,5%). Aliae condiciones associatae cum PPD sunt hypertension (15,8%), diabetes (10,5%) et aliae. Historia medicamentorum revelavit usum statinorum (13,2%), beta‑obstructorum (10,5%) et aliorum. Possibiles factores associati cum PPD sunt recentis infectionis respiratoriae superioris (5,3%), diuturna statio quae ducit ad pressuram orthostaticam altam (2,6%) et exercitatio intensa (2,6%). Curatio administrata est 36 aegeribus (94,7%): antihistaminica oralia, pentoxifyllinum, steroides topici et/vel phototherapia.
    Information on 113 patients with PPD was analyzed, and 38 subjects with skin biopsy were included for this study. Schamberg's disease was the most frequent clinical type (60.5%). Concomitant diseases included hypertension (15.8%), diabetes (10.5%), and others. Associated medication histories included statins (13.2%), beta blockers (10.5%), and others. Possibly associated etiologic factors were recent upper respiratory infection (5.3%), high orthostatic pressure due to prolonged standing (2.6%), and strenuous exercise (2.6%). A total of 36 patients (94.7%) were treated with one or more treatment methods, including oral antihistamines, pentoxifylline, topical steroids, and/or phototherapy.